NEURONOPATHIC LYSOSOMAL STORAGE DISEASES: CLINICAL AND PATHOLOGIC FINDINGS

被引:12
|
作者
Prada, Carlos E. [1 ,2 ]
Grabowski, Gregory A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA
[2] Cardiovasc Fdn Colombia, Ctr Genom Med & Metab, Floridablanca, Colombia
关键词
lysosomal storage diseases; neuronopathic disease; autophagy; inflammation; cell death; pathogenesis; NEURONAL CEROID-LIPOFUSCINOSES; ACID MALTASE DEFICIENCY; TAY-SACHS-DISEASE; GLOBOID-CELL LEUKODYSTROPHY; GAUCHER-DISEASE; SANDHOFF-DISEASE; KRABBE-DISEASE; PARKINSON-DISEASE; MOUSE MODEL; NEUROAXONAL DYSTROPHY;
D O I
10.1002/ddrr.1116
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The lysosomal-autophagocytic system diseases (LASDs) affect multiple body systems including the central nervous system (CNS). The progressive CNS pathology has its onset at different ages, leading to neurodegeneration and early death. Methods: Literature review provided insight into the current clinical neurological findings, phenotypic spectrum, and pathogenic mechanisms of LASDs with primary neurological involvement. Conclusions: CNS signs and symptoms are variable and related to the disease-specific underlying pathogenesis. LAS dysfunction leads to diverse global cellular consequences in the CNS ranging from specific axonal and dendritic abnormalities to neuronal death. Pathogenic mechanisms for disease progression vary from impaired autophagy, massive storage, regional involvement, to end-stage inflammation. Some of these features are also found in adult neurodegenerative disorders, for example, Parkinson's and Alzheimer's diseases. Lack of effective therapies is a significant unmet medical need. (C) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:226 / 246
页数:21
相关论文
共 50 条
  • [21] Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression
    Para, Camila
    Bose, Poulomee
    Pshezhetsky, Alexey V.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [22] Sphingolipid lysosomal storage diseases: from bench to bedside
    Abed Rabbo, Muna
    Khodour, Yara
    Kaguni, Laurie S.
    Stiban, Johnny
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)
  • [23] Therapeutic Approaches in Lysosomal Storage Diseases
    Fernandez-Pereira, Carlos
    San Millan-Tejado, Beatriz
    Gallardo-Gomez, Maria
    Perez-Marquez, Tania
    Alves-Villar, Marta
    Melcon-Crespo, Cristina
    Fernandez-Martin, Julian
    Ortolano, Saida
    BIOMOLECULES, 2021, 11 (12)
  • [24] Epidemiology of lysosomal storage diseases in Sweden
    Hult, Malin
    Darin, Niklas
    von Dobeln, Ulrika
    Mansson, Jan-Eric
    ACTA PAEDIATRICA, 2014, 103 (12) : 1258 - 1263
  • [25] Rheumatologic aspects of lysosomal storage diseases
    Manger, Bernhard
    Mengel, Eugen
    Schaefer, Roland M.
    CLINICAL RHEUMATOLOGY, 2007, 26 (03) : 335 - 341
  • [26] Rheumatologic aspects of lysosomal storage diseases
    Bernhard Manger
    Eugen Mengel
    Roland M. Schaefer
    Clinical Rheumatology, 2007, 26 : 335 - 341
  • [27] Mucopolysaccharidoses and Other Lysosomal Storage Diseases
    Lampe, Christina
    Bellettato, Cinzia Maria
    Karabul, Nesrin
    Scarpa, Maurizio
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2013, 39 (02) : 431 - +
  • [28] Lysosomal storage diseases
    Platt, Frances M.
    d'Azzo, Alessandra
    Davidson, Beverly L.
    Neufeld, Elizabeth F.
    Tifft, Cynthia J.
    NATURE REVIEWS DISEASE PRIMERS, 2018, 4
  • [29] Calcium homeostasis in lysosomal storage diseases
    Futerman, A. H.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 : S6 - S7
  • [30] Biomarkers in lysosomal storage diseases: a review
    Cox, TM
    ACTA PAEDIATRICA, 2005, 94 : 39 - 42